Compounds > ono 1078
Page last updated: 2024-08-16

ono 1078 and tacrolimus

ono 1078 has been researched along with tacrolimus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Hirasawa, N; Honda, M; Okada, M; Ozawa, M; Sano, K; Shirota, H; Tagami, H; Tamura, G; Terui, T1
Fukushima, C; Kawano, T; Kohno, S; Kondo, Y; Machida, I; Matsuse, H; Obase, Y; Shimoda, T; Tomari, S1
Aizawa-Yashiro, T; Ito, E; Takahashi, T; Tanaka, H; Tsuruga, K; Watanabe, S1

Other Studies

4 other study(ies) available for ono 1078 and tacrolimus

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells.
    The Journal of investigative dermatology, 2001, Volume: 117, Issue:2

    Topics: Animals; Cells, Cultured; Chromones; Dermatitis, Atopic; Disease Models, Animal; Ear; Edema; Enzyme Inhibitors; Eosinophils; Hypersensitivity; Immunosuppressive Agents; Leukotriene Antagonists; Male; Mice; Mice, Inbred BALB C; Neutrophils; Ovalbumin; Oxadiazoles; Pyrimidinones; Skin; Tacrolimus; Th1 Cells; Th2 Cells

2001
Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2003, Volume: 33, Issue:6

    Topics: Adult; Allergens; Antigens, Dermatophagoides; Arthropod Proteins; Asthma; Cells, Cultured; Chromones; Cysteine Endopeptidases; Cytokines; Dermatophagoides farinae; Dexamethasone; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Leukotriene Antagonists; Male; NF-kappa B; Tacrolimus; Translocation, Genetic; Tumor Necrosis Factor-alpha

2003
Successful multidrug treatment of a pediatric patient with severe Churg-Strauss syndrome refractory to prednisolone.
    The Tohoku journal of experimental medicine, 2011, Volume: 225, Issue:2

    Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Chromones; Churg-Strauss Syndrome; Cyclophosphamide; Drug Resistance; Drug Resistance, Multiple; Eosinophilia; Humans; Immunosuppressive Agents; Japan; Methylprednisolone; Pericarditis; Pleura; Prednisolone; Tacrolimus; Ulcer

2011